Clinical Trials Browser

INDUSTRY × Interventional × dapagliflozin × Clear all

NCT07033585 2025-07-11

GD-T2D

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

NCT04899349 2024-10-09

EPIK-B4

Phase 2 Terminated

2 enrolled 8 charts

Breast Neoplasms, Hyperglycemia, Hereditary Sensory and Autonomic Neuropathies